<DOC>
	<DOCNO>NCT00054054</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one chemotherapy drug radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy radiation therapy treat patient stage III stage IV head neck cancer .</brief_summary>
	<brief_title>S0216 , Combination Chemotherapy RT Treating Patients With Stage III Stage IV Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine overall survival patient stage III IV squamous cell head neck cancer treat docetaxel , cisplatin , fluorouracil follow accelerated fractionation/concomitant boost radiotherapy cisplatin . - Determine unconfirmed complete response rate patient treatment induction chemotherapy . - Determine overall complete response rate ( confirm unconfirmed ) patient treat regimen . - Determine toxic effect regimen patient . OUTLINE : - Induction Chemotherapy : Patients receive docetaxel IV 1 hour cisplatin IV 30-60 minute day 1 fluorouracil IV continuously day 1-4 . Treatment repeat every 21 day 2 course absence unacceptable toxicity . - Chemoradiotherapy : Beginning within 3-4 week administration second course induction chemotherapy , patient receive accelerate fractionation radiotherapy daily , 5 day per week , 6 week concomitant boost radiotherapy daily , 5 day week , last 2.5 week radiotherapy . Patients also receive concurrent cisplatin IV 30-60 minute day 1 22 . Patients follow every 2 month 1 year , every 3 month 2 year , every 4 month 1 year , every 6 month 1 year . PROJECTED ACCRUAL : A total 60 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck ( exclude lip , nasopharynx , paranasal sinus , salivary gland ) biopsy fine needle aspirate primary lesion neck mass Stage III IV disease No evidence distant metastasis Negative chest xray Primary site head neck region must identify No unknown primary site Considered appropriate definitive radiotherapy curative intent PATIENT CHARACTERISTICS : Age 18 Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Granulocyte count great 1,500/mm^3 Platelet count great 100,000/mm^3 Hepatic Bilirubin great upper limit normal ( ULN ) Alkaline phosphatase less 2 time ULN ALT AST less 1.5 time ULN Renal Creatinine le 1.5 mg/dL Cardiovascular No myocardial infarction within past 3 month No unstable uncontrolled angina Other Not pregnant nursing Fertile patient must use effective contraception No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer currently complete remission No evidence preexist peripheral neuropathy No active systemic infection No history hypersensitivity reaction product contain polysorbate 80 PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy See Disease Characteristics No prior radiotherapy Surgery No prior surgery head neck cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
</DOC>